These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 22915052)
21. Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome. Ho AY; Adams S; Shaikh H; Pagliuca A; Devereux S; Mufti GJ Bone Marrow Transplant; 2002 May; 29(10):867-9. PubMed ID: 12058237 [TBL] [Abstract][Full Text] [Related]
22. Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation. Coppoletta S; Tedone E; Galano B; Soracco M; Raiola AM; Lamparelli T; Gualandi F; Bregante S; Ibatici A; di Grazia C; Dominietto A; Varaldo R; Bruno B; Frassoni F; Van Lint MT; Bacigalupo A Biol Blood Marrow Transplant; 2011 Jun; 17(6):901-7. PubMed ID: 20950702 [TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report. Dutta R; Miao SY; Phan P; Fernandez-Pol S; Shiraz P; Ho D; Mannis GN; Zhang TY J Med Case Rep; 2021 Mar; 15(1):170. PubMed ID: 33773605 [TBL] [Abstract][Full Text] [Related]
24. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation. Sundin M; Le Blanc K; Ringdén O; Barkholt L; Omazic B; Lergin C; Levitsky V; Remberger M Haematologica; 2006 Aug; 91(8):1059-67. PubMed ID: 16885046 [TBL] [Abstract][Full Text] [Related]
25. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load. Calabrese F; Loy M; Lunardi F; Marino D; Aversa SM; Rea F Transpl Infect Dis; 2010 Aug; 12(4):342-6. PubMed ID: 20030794 [TBL] [Abstract][Full Text] [Related]
26. Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q. Mitteldorf C; Bertsch HP; Baumgart M; Haase D; Wulf G; Schön MP; Rosenwald A; Neumann C; Kaune KM J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1225-9. PubMed ID: 21923812 [TBL] [Abstract][Full Text] [Related]
27. Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection: A case report. Yamamoto M; Shindo M; Funayama T; Sumi C; Saito T; Toki Y; Hatayama M; Imadome KI; Mizukami Y; Okumura T Medicine (Baltimore); 2022 Mar; 101(12):e29055. PubMed ID: 35357349 [TBL] [Abstract][Full Text] [Related]
28. High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts. Hoegh-Petersen M; Goodyear D; Geddes MN; Liu S; Ugarte-Torres A; Liu Y; Walker JT; Fonseca K; Daly A; Duggan P; Stewart D; Russell JA; Storek J Bone Marrow Transplant; 2011 Aug; 46(8):1104-12. PubMed ID: 21057556 [TBL] [Abstract][Full Text] [Related]
29. Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review. Su YY; Yu YF; Yan ZY; Zhao YJ; Lou JW; Xue F; Xu M; Feng Q; Ji XB; Dong XY; Wang W; Liu CF; Peng J; Liu XG Diagn Pathol; 2024 Sep; 19(1):122. PubMed ID: 39244586 [TBL] [Abstract][Full Text] [Related]
30. Isolated cerebral post-transplant lymphoproliferative disorder in a lymphoma recipient. Tang TC; Chuang WY; Chang H J Cancer Res Ther; 2013; 9(3):534-6. PubMed ID: 24126003 [TBL] [Abstract][Full Text] [Related]
32. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Lim WH; Russ GR; Coates PT Nephrology (Carlton); 2006 Aug; 11(4):355-66. PubMed ID: 16889577 [TBL] [Abstract][Full Text] [Related]
33. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction. Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070 [TBL] [Abstract][Full Text] [Related]
34. Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute. Hou HA; Yao M; Tang JL; Chen YK; Ko BS; Huang SY; Tien HF; Chang HH; Lu MY; Lin TT; Lin KH; Hsiao CH; Lin CW; Chen YC Bone Marrow Transplant; 2009 Feb; 43(4):315-21. PubMed ID: 18836488 [TBL] [Abstract][Full Text] [Related]
35. EBV lymphoproliferative disease of host origin after haploidentical stem cell transplantation. Kasow KA; Leung W; Horwitz EM; Woodard P; Handgretinger R; Hale GA Pediatr Blood Cancer; 2007 Nov; 49(6):869-72. PubMed ID: 16421900 [TBL] [Abstract][Full Text] [Related]
36. The impact of monitoring Epstein-Barr virus PCR in paediatric bone marrow transplant patients: can it successfully predict outcome and guide intervention? Greenfield HM; Gharib MI; Turner AJ; Guiver M; Carr T; Will AM; Wynn RF Pediatr Blood Cancer; 2006 Aug; 47(2):200-5. PubMed ID: 16206207 [TBL] [Abstract][Full Text] [Related]